Cargando…
Adverse Drug Reactions in the Intensive Care Unit
Adverse drug reactions (ADRs) are undesirable effects of medications used in normal doses [1]. ADRs can occur during treatment in an intensive care unit (ICU) or result in ICU admissions. A meta-analysis of 4139 studies suggests the incidence of ADRs among hospitalized patients is 17% [2]. Because o...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153447/ http://dx.doi.org/10.1007/978-3-319-17900-1_33 |
_version_ | 1783521655982653440 |
---|---|
author | Moore, Philip Burkhart, Keith |
author_facet | Moore, Philip Burkhart, Keith |
author_sort | Moore, Philip |
collection | PubMed |
description | Adverse drug reactions (ADRs) are undesirable effects of medications used in normal doses [1]. ADRs can occur during treatment in an intensive care unit (ICU) or result in ICU admissions. A meta-analysis of 4139 studies suggests the incidence of ADRs among hospitalized patients is 17% [2]. Because of underreporting and misdiagnosis, the incidence of ADRs may be much higher and has been reported to be as high as 36% [3]. Critically ill patients are at especially high risk because of medical complexity, numerous high-alert medications, complex and often challenging drug dosing and medication regimens, and opportunity for error related to the distractions of the ICU environment [4]. Table 1 summarizes the ADRs included in this chapter. |
format | Online Article Text |
id | pubmed-7153447 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71534472020-04-13 Adverse Drug Reactions in the Intensive Care Unit Moore, Philip Burkhart, Keith Critical Care Toxicology Article Adverse drug reactions (ADRs) are undesirable effects of medications used in normal doses [1]. ADRs can occur during treatment in an intensive care unit (ICU) or result in ICU admissions. A meta-analysis of 4139 studies suggests the incidence of ADRs among hospitalized patients is 17% [2]. Because of underreporting and misdiagnosis, the incidence of ADRs may be much higher and has been reported to be as high as 36% [3]. Critically ill patients are at especially high risk because of medical complexity, numerous high-alert medications, complex and often challenging drug dosing and medication regimens, and opportunity for error related to the distractions of the ICU environment [4]. Table 1 summarizes the ADRs included in this chapter. 2017-05-17 /pmc/articles/PMC7153447/ http://dx.doi.org/10.1007/978-3-319-17900-1_33 Text en © Springer International Publishing AG 2017 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Moore, Philip Burkhart, Keith Adverse Drug Reactions in the Intensive Care Unit |
title | Adverse Drug Reactions in the Intensive Care Unit |
title_full | Adverse Drug Reactions in the Intensive Care Unit |
title_fullStr | Adverse Drug Reactions in the Intensive Care Unit |
title_full_unstemmed | Adverse Drug Reactions in the Intensive Care Unit |
title_short | Adverse Drug Reactions in the Intensive Care Unit |
title_sort | adverse drug reactions in the intensive care unit |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153447/ http://dx.doi.org/10.1007/978-3-319-17900-1_33 |
work_keys_str_mv | AT moorephilip adversedrugreactionsintheintensivecareunit AT burkhartkeith adversedrugreactionsintheintensivecareunit |